TY - JOUR
T1 - Steroid hormone receptor status of mouse mammary stem cells
AU - Asselin-Labat, Marie Liesse
AU - Shackleton, Mark
AU - Stingl, John
AU - Vaillant, François
AU - Forrest, Natasha C.
AU - Eaves, Connie J.
AU - Visvader, Jane E.
AU - Lindeman, Geoffrey J.
PY - 2006/7/19
Y1 - 2006/7/19
N2 - The estrogen receptor α (ERα), progesterone receptor (PR), and erbB2 (Her2 in humans) are important prognostic markers of human breast cancer, and they are variably expressed in different subtypes of breast cancer. The basal subtype, for example, is negative for ERα, PR, and Her2 by immunohistochemistry. We investigated the expression of these signaling molecules in enriched populations of mouse mammary stem cells and luminal cells that were isolated according to their differential expression of CD24 and the α6β1-integrin complex. We found that the basal population, which is enriched in mouse mammary stem cells, did not express ERα, PR, or ErbB2/Her2 but did express epidermal growth factor receptor (EGFR)/ErbB1, whereas the subset of cells enriched for luminal cells expressed ERα (37% of cells) and PR (40% of cells) but not ErbB2/Her2 or EGFR/ErbB1. Ovariectomy confirmed the importance of estrogen signaling to luminal cell proliferation but had no effect on the size of the mouse mammary stem cell-enriched population. Thus, mouse mammary stem cells were negative for ERα, PR, and ErbB2 and appeared to share common properties with poor-prognosis basal breast cancer.
AB - The estrogen receptor α (ERα), progesterone receptor (PR), and erbB2 (Her2 in humans) are important prognostic markers of human breast cancer, and they are variably expressed in different subtypes of breast cancer. The basal subtype, for example, is negative for ERα, PR, and Her2 by immunohistochemistry. We investigated the expression of these signaling molecules in enriched populations of mouse mammary stem cells and luminal cells that were isolated according to their differential expression of CD24 and the α6β1-integrin complex. We found that the basal population, which is enriched in mouse mammary stem cells, did not express ERα, PR, or ErbB2/Her2 but did express epidermal growth factor receptor (EGFR)/ErbB1, whereas the subset of cells enriched for luminal cells expressed ERα (37% of cells) and PR (40% of cells) but not ErbB2/Her2 or EGFR/ErbB1. Ovariectomy confirmed the importance of estrogen signaling to luminal cell proliferation but had no effect on the size of the mouse mammary stem cell-enriched population. Thus, mouse mammary stem cells were negative for ERα, PR, and ErbB2 and appeared to share common properties with poor-prognosis basal breast cancer.
UR - http://www.scopus.com/inward/record.url?scp=33746709476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746709476&partnerID=8YFLogxK
U2 - 10.1093/jnci/djj267
DO - 10.1093/jnci/djj267
M3 - Article
C2 - 16849684
AN - SCOPUS:33746709476
SN - 0027-8874
VL - 98
SP - 1011
EP - 1014
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 14
ER -